| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2016/035029WO2017209732A1 (en) | 2016-05-31 | 2016-05-31 | A long acting pharmaceutical composition of protease inhibitor |
| Publication Number | Publication Date |
|---|---|
| EP3463374A1 EP3463374A1 (en) | 2019-04-10 |
| EP3463374A4true EP3463374A4 (en) | 2020-01-22 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP16904195.1AWithdrawnEP3463374A4 (en) | 2016-05-31 | 2016-05-31 | PROLONGED-ACTION PHARMACEUTICAL COMPOSITION BASED ON A PROTEASE INHIBITOR |
| Country | Link |
|---|---|
| EP (1) | EP3463374A4 (en) |
| JP (1) | JP6704058B2 (en) |
| CN (1) | CN109475563A (en) |
| WO (1) | WO2017209732A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6068858A (en)* | 1997-02-13 | 2000-05-30 | Elan Pharma International Limited | Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998057648A1 (en)* | 1997-06-16 | 1998-12-23 | Vertex Pharmaceuticals Incorporated | Methods of increasing the bioavailability of stable crystal polymorphs of a compound |
| US7388008B2 (en)* | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| ES2539527T3 (en)* | 2005-04-27 | 2015-07-01 | Taimed Biologics, Inc. | Method for improving the pharmacokinetics of protease inhibitors and protease inhibitor precursors |
| CN101405293B (en)* | 2005-11-30 | 2013-03-13 | 中裕新药股份有限公司 | Lysine-based prodrugs of aspartyl protease inhibitors and methods of making the same |
| ES2511790T3 (en)* | 2006-05-30 | 2014-10-23 | Janssen R&D Ireland | Lysine-related derivatives such as HIV aspartyl protease inhibitors |
| MX2009000158A (en)* | 2006-06-23 | 2009-01-23 | Tibotec Pharm Ltd | Aqueous suspensions of tmc278. |
| JP2010502569A (en)* | 2006-07-17 | 2010-01-28 | アンブリリア バイオファーマ インコーポレイテッド | How to improve pharmacokinetics |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6068858A (en)* | 1997-02-13 | 2000-05-30 | Elan Pharma International Limited | Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| Title |
|---|
| DAS MALAY K ET AL: "Nano-ART and NeuroAIDS", DRUG DELIVERY AND TRANSLATIONAL RESEARCH, SPRINGER, GERMANY, vol. 6, no. 5, 2 May 2016 (2016-05-02), pages 452 - 472, XP036042525, ISSN: 2190-393X, [retrieved on 20160502], DOI: 10.1007/S13346-016-0293-Z* |
| LALIT KUMAR ET AL: "Nanotechnology: A magic bullet for HIV AIDS treatment", ARTIFICIAL CELLS, NANOMEDICINE AND BIOTECHNOLOGY, vol. 43, no. 2, 25 February 2014 (2014-02-25), US, pages 71 - 86, XP055653795, ISSN: 2169-1401, DOI: 10.3109/21691401.2014.883400* |
| See also references ofWO2017209732A1* |
| Publication number | Publication date |
|---|---|
| WO2017209732A1 (en) | 2017-12-07 |
| JP2019510002A (en) | 2019-04-11 |
| EP3463374A1 (en) | 2019-04-10 |
| CN109475563A (en) | 2019-03-15 |
| JP6704058B2 (en) | 2020-06-03 |
| Publication | Publication Date | Title |
|---|---|---|
| MA44725A (en) | LSD1 INHIBITOR FORMULATIONS | |
| EP3441495A4 (en) | STAINLESS STEEL MATERIAL BASED ON AUSTENITY | |
| EP3750149C0 (en) | BILLBOARD | |
| EP3416610A4 (en) | COMPOSITIONS BASED ON POLYURED CAPSULES | |
| EP3388084A4 (en) | POLYTHERAPY BASED ON PD-1 SIGNAL INHIBITORS | |
| EP3467417A4 (en) | COAST-SIDE REFRIGERATOR HAVING A CAMERA-TYPE DEVICE | |
| EP3397705C0 (en) | WATER-BASED COATINGS FORM A BARRIER | |
| EP3846972A4 (en) | MODULAR TOOL CONTAINER | |
| DK3679133T3 (en) | Performance-enhanced protease variants | |
| MA43402A (en) | PHARMACEUTICAL COMPOSITION INCLUDING A POWERFUL URAT1 INHIBITOR | |
| MA43649A (en) | FORMULATIONS / COMPOSITIONS INCLUDING A BTK INHIBITOR | |
| EP3428240A4 (en) | WATER-BASED COATING COMPOSITION | |
| EP3359150A4 (en) | POLYTHERAPY USING GLUTAMINASE INHIBITORS AND IMMUNO-ONCOLOGIC AGENTS | |
| DK3595667T3 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING A JAK INHIBITOR | |
| EP3339462A4 (en) | STAINLESS STEEL SHEET BASED ON AUSTENITY | |
| MA43650A (en) | FORMULATIONS / COMPOSITIONS INCLUDING A BTK INHIBITOR | |
| EP3787641A4 (en) | HYPOCHLOROUS ACID-BASED EYELID CLEANSER | |
| FR3034987B1 (en) | COMPOSITION BASED ON TRANS-RESVERATROL OR A TRANS-RESVERATROL DERIVATIVE | |
| FR3049465B1 (en) | PREVENTIVE AND CURATIVE PHARMACEUTICAL COMPOSITION BASED ON PEROXOMETALLATE | |
| EP3305854A4 (en) | COMPOSITION AND ARTICLES BASED ON AQUEOUS URETHANE RESIN | |
| EP3487353A4 (en) | Sinking pump actuation device | |
| EP3329515A4 (en) | FUNCTIONAL METAL OXIDE MICROELECTRONIC DEVICES | |
| EP3366730A4 (en) | INK COMPOSITION BASED ON WATER | |
| EP3511120A4 (en) | MACHINE TOOL HAVING A DISPLAY DEVICE | |
| EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION |
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE | |
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase | Free format text:ORIGINAL CODE: 0009012 | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: REQUEST FOR EXAMINATION WAS MADE | |
| 17P | Request for examination filed | Effective date:20180716 | |
| AK | Designated contracting states | Kind code of ref document:A1 Designated state(s):AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | |
| AX | Request for extension of the european patent | Extension state:BA ME | |
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code | Ref country code:DE Ref legal event code:R079 Free format text:PREVIOUS MAIN CLASS: A61K0031551000 Ipc:A61K0031630000 | |
| A4 | Supplementary search report drawn up and despatched | Effective date:20200107 | |
| RIC1 | Information provided on ipc code assigned before grant | Ipc:A61K 31/661 20060101ALI20191219BHEP Ipc:A61K 31/63 20060101AFI20191219BHEP Ipc:A61K 9/10 20060101ALI20191219BHEP Ipc:A61P 31/18 20060101ALI20191219BHEP Ipc:A61K 9/00 20060101ALI20191219BHEP Ipc:A61K 9/51 20060101ALI20191219BHEP | |
| STAA | Information on the status of an ep patent application or granted ep patent | Free format text:STATUS: THE APPLICATION HAS BEEN WITHDRAWN | |
| 18W | Application withdrawn | Effective date:20230205 |